Switch theme
Sign up to access all valuation multiples
XP Chemistries AB is an inventive biotechnology company that develops and patents novel nature inspired chemical processes for the production of high-quality and sustainable natural chemicals.
2015
3
LTM Revenue $0.3M
LTM EBITDA -$0.7M
$7.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
XP Chemistries has a last 12-month revenue of $0.3M and a last 12-month EBITDA of -$0.7M.
In the most recent fiscal year, XP Chemistries achieved revenue of $30K and an EBITDA of -$0.8M.
XP Chemistries expects next 12-month revenue of XXX and NTM EBITDA of XXX
See XP Chemistries valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.1M | $30K | XXX | XXX | XXX |
| Gross Profit | $0.1M | $35K | XXX | XXX | XXX |
| Gross Margin | 74% | 118% | XXX | XXX | XXX |
| EBITDA | -$0.9M | -$0.8M | XXX | XXX | XXX |
| EBITDA Margin | -1310% | -2647% | XXX | XXX | XXX |
| Net Profit | -$0.8M | -$0.8M | XXX | XXX | XXX |
| Net Margin | -1193% | -2831% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 27, 2025, XP Chemistries's stock price is SEK 0 (or $0).
XP Chemistries has current market cap of SEK 73.4M (or $7.7M), and EV of SEK 71.2M (or $7.5M).
See XP Chemistries trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7.5M | $7.7M | XXX | XXX | XXX | XXX | $-0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 27, 2025, XP Chemistries has market cap of $7.7M and EV of $7.5M.
XP Chemistries's trades at 23.8x LTM EV/Revenue multiple, and -11.1x LTM EBITDA.
Analysts estimate XP Chemistries's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for XP Chemistries and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $7.5M | XXX | XXX | XXX |
| EV/Revenue | 250.9x | XXX | XXX | XXX |
| EV/EBITDA | -9.5x | XXX | XXX | XXX |
| P/E | -10.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -8.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialXP Chemistries's NTM/LTM revenue growth is 344%
XP Chemistries's revenue per employee for the last fiscal year averaged $10K, while opex per employee averaged n/a for the same period.
Over next 12 months, XP Chemistries's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate XP Chemistries's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for XP Chemistries and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -57% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | -14% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -23% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $10K | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 33% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
XP Chemistries acquired XXX companies to date.
Last acquisition by XP Chemistries was XXXXXXXX, XXXXX XXXXX XXXXXX . XP Chemistries acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was XP Chemistries founded? | XP Chemistries was founded in 2015. |
| Where is XP Chemistries headquartered? | XP Chemistries is headquartered in Sweden. |
| How many employees does XP Chemistries have? | As of today, XP Chemistries has 3 employees. |
| Is XP Chemistries publicy listed? | Yes, XP Chemistries is a public company listed on STO. |
| What is the stock symbol of XP Chemistries? | XP Chemistries trades under XPC ticker. |
| When did XP Chemistries go public? | XP Chemistries went public in 2021. |
| Who are competitors of XP Chemistries? | Similar companies to XP Chemistries include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of XP Chemistries? | XP Chemistries's current market cap is $7.7M |
| What is the current revenue of XP Chemistries? | XP Chemistries's last 12-month revenue is $0.3M. |
| What is the current EBITDA of XP Chemistries? | XP Chemistries's last 12-month EBITDA is -$0.7M. |
| What is the current EV/Revenue multiple of XP Chemistries? | Current revenue multiple of XP Chemistries is 23.8x. |
| What is the current EV/EBITDA multiple of XP Chemistries? | Current EBITDA multiple of XP Chemistries is -11.1x. |
| What is the current revenue growth of XP Chemistries? | XP Chemistries revenue growth between 2023 and 2024 was -57%. |
| Is XP Chemistries profitable? | Yes, XP Chemistries is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
